4276 - 4300 of 8444 Results
Title
Year
- The Pseudodystonia of Paroxysmal Sympathetic Hyperactivity: A Reversible Post‐Anoxic Complication2020OPENTitle: The Pseudodystonia of Paroxysmal Sympathetic Hyperactivity: A Reversible Post‐Anoxic ComplicationJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 8Start Page: 987End Page: 989Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13095Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13095Citation Count: 1
-
RESTRICTEDTitle: Inflammation in Experimental Models of α‐SynucleinopathiesJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 37End Page: 49Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28264Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115204Citation Count: 24
-
RESTRICTEDTitle: Apathy in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 95Issue #: 20Start Page: 893End Page: 894Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000010961Citation Count: 2
- Biomarkers of environmental manganese exposure and associations with childhood neurodevelopment: a systematic review and meta-analysis2020RESTRICTEDTitle: Biomarkers of environmental manganese exposure and associations with childhood neurodevelopment: a systematic review and meta-analysisJournal Name: Environmental HealthPublisher: Springer Science and Business Media LLCVol: 19Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12940-020-00659-xBest OA location URL: https://ehjournal.biomedcentral.com/track/pdf/10.1186/s12940-020-00659-xCitation Count: 49
-
RESTRICTEDTitle: COVID-19's impact on neurology and national solutions through educationJournal Name: British Journal of Neuroscience NursingPublisher: Mark Allen GroupVol: 16Issue #: 5Start Page: 209End Page: 214Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.12968/bjnn.2020.16.5.209Citation Count: 0
-
RESTRICTEDTitle: Microglia modulate neurodegeneration in Alzheimer’s and Parkinson’s diseasesJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 370Issue #: 6512Start Page: 66End Page: 69Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/science.abb8587Best OA location URL: https://discovery.ucl.ac.uk/10113826/1/Hong_abb8587%20copy.pdfCitation Count: 229
-
OPENTitle: Pathway-specific dysregulation of striatal excitatory synapses by LRRK2 mutationsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.58997Best OA location URL: https://cdn.elifesciences.org/articles/58997/elife-58997-v2.pdfCitation Count: 49
-
OPENTitle: Analysis of heterozygous PRKN variants and copy number variations in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: e28End Page: e28Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.123Best OA location URL: https://doi.org/10.1101/2020.05.07.20072728Citation Count: 6
-
RESTRICTEDTitle: Approach to Cognitive Impairment in Parkinson’s DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1495End Page: 1510Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00963-xBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00963-x.pdfCitation Count: 38
- Approaches to Disease Modification for Parkinson’s Disease: Clinical Trials and Lessons Learned2020RESTRICTEDTitle: Approaches to Disease Modification for Parkinson’s Disease: Clinical Trials and Lessons LearnedJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1393End Page: 1405Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00964-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00964-w.pdfCitation Count: 20
- Association of caffeine and related analytes with resistance to Parkinson disease among LRRK2 mutation carriers2020OPENTitle: Association of caffeine and related analytes with resistance to Parkinson disease among LRRK2 mutation carriersJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 95Issue #: 24Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000010863Best OA location URL: https://n.neurology.org/content/neurology/95/24/e3428.full.pdfCitation Count: 48
-
OPENTitle: BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson's DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1785End Page: 1795Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1007/s13311-020-00965-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00965-9.pdfCitation Count: 17
- Characteristics, treatment patterns and disease burden of people with Parkinson's disease in the Parkinson's disease real-world impact assessment (PRISM) study2020RESTRICTEDTitle: Characteristics, treatment patterns and disease burden of people with Parkinson's disease in the Parkinson's disease real-world impact assessment (PRISM) studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: e86End Page: e86Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.312Citation Count: 0
- Comparison of Patient and Expert Perceptions of the Attainment of Research Milestones in Parkinson's Disease2020OPENTitle: Comparison of Patient and Expert Perceptions of the Attainment of Research Milestones in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 171End Page: 177Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.28319Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28319Citation Count: 4
- Complementary Therapies in Parkinson Disease: a Review of Acupuncture, Tai Chi, Qi Gong, Yoga, and Cannabis2020RESTRICTEDTitle: Complementary Therapies in Parkinson Disease: a Review of Acupuncture, Tai Chi, Qi Gong, Yoga, and CannabisJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1434End Page: 1455Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00900-yBest OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00900-y.pdfCitation Count: 49
- Comprehensive Analysis of Familial Parkinsonism Genes in Rapid‐Eye‐Movement Sleep Behavior Disorder2020OPENTitle: Comprehensive Analysis of Familial Parkinsonism Genes in Rapid‐Eye‐Movement Sleep Behavior DisorderJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 235End Page: 240Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28318Best OA location URL: http://escholarship.mcgill.ca/downloads/fb494f269Citation Count: 13
- Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical Treatments2020RESTRICTEDTitle: Current Management of Tics and Tourette Syndrome: Behavioral, Pharmacologic, and Surgical TreatmentsJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1681End Page: 1693Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-020-00914-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00914-6.pdfCitation Count: 58
- Detecting bradykinesia in early morning “OFF” episodes: a large database study using the Personal KinetiGraph® (PKG®)2020RESTRICTEDTitle: Detecting bradykinesia in early morning “OFF” episodes: a large database study using the Personal KinetiGraph® (PKG®)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: e88End Page: e89Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.322Citation Count: 0
-
OPENTitle: Differences in the Presentation and Progression of Parkinson's Disease by SexJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 106End Page: 117Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28312Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28312Citation Count: 66
-
RESTRICTEDTitle: Emerging Targeted Therapeutics for Genetic Subtypes of ParkinsonismJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1378End Page: 1392Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s13311-020-00920-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00920-8.pdfCitation Count: 27
-
RESTRICTEDTitle: Evaluation of motor response inhibition in Parkinson's Disease and Alzheimer's DiseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: e86End Page: e87Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.314Citation Count: 0
-
RESTRICTEDTitle: Exploring the clinical burden of OFF periods in Parkinson diseaseJournal Name: The American Journal of Managed CarePublisher: Managed Care and Healthcare Communications, LLCVol: 26Issue #: Suppl 12Start Page: S255End Page: S264Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.37765/ajmc.2020.88517Citation Count: 14
- Exposure-response efficacy model of apomorphine sublingual film for the on-demand treatment of “OFF” episodes in patients with Parkinson's disease2020RESTRICTEDTitle: Exposure-response efficacy model of apomorphine sublingual film for the on-demand treatment of “OFF” episodes in patients with Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: e85End Page: e86Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.311Citation Count: 2
-
RESTRICTEDTitle: Gene and Cell-Based Therapies for Parkinson's Disease: Where Are We?Journal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 17Issue #: 4Start Page: 1539End Page: 1562Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1007/s13311-020-00940-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-020-00940-4.pdfCitation Count: 23
-
OPENTitle: If LRRK2 Set the Fire, Can Nonsteroidal Anti‐inflammatory Drugs Wet the Flames?Journal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 10Start Page: 1727End Page: 1730Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28240Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28240Citation Count: 4